JOA - 2026-11-14 - Journal Article
Extensor Mechanism Allograft After Total Knee Arthroplasty: An Effective Procedure With a Major Risk of Complications.
Ecki M, Deroche E, Servien E, Lustig S, Batailler C
Topics
Key Takeaway
Extensor mechanism allograft after TKA yields 59.1% survival free of aseptic failure at 48 months, with 37.3% of patients meeting failure criteria and only 52.9% satisfied at mean 39.8 months.
Summary Depth
Choose how much analysis to show on this article page.
Summary
This single-center retrospective study evaluated functional outcomes, survival, and complications of complete extensor mechanism allograft (EMA) in 51 TKA knees with minimum 2-year follow-up, stratified by whether simultaneous revision TKA was performed. Kaplan-Meier survival free of aseptic EMA failure was 79.5% at 24 months and 59.1% at 48 months, with a mean active extension deficit of 22.0° ± 24.4°. Complication rate was 29.4%, surgical reoperation for EMA failure occurred in 17.6%, and quadriceps tendon rupture subgroup carried significantly higher failure risk (P=0.045); concomitant revision TKA did not worsen outcomes.
Key Limitation
Retrospective single-center design with heterogeneous rupture etiologies and no standardized rehabilitation protocol introduces selection bias and limits causal inference.
Original Abstract
PURPOSE
Chronic extensor mechanism rupture is a rare but dreaded complication of total knee arthroplasty (TKA). This study aimed to describe the functional outcomes, survival rates, complications, and revisions after complete extensor mechanism allograft (EMA) on TKA at a minimal follow-up of two years.
METHODS
This retrospective single-center study included all patients who underwent complete EMA after a TKA between 2017 and 2022, who had a minimum follow-up of 24 months (range, 24.0 to 85.0). Of the 60 EMAs, 51 knees were included. The mean patient age was 66 years (range, 49.9 to 81.4). Most extensor mechanism ruptures were on the patellar tendon (39.2%) and the quadricipital tendon (33.3%). This cohort was divided into two subgroups: EMA with (n = 20) or without (n = 31) simultaneous RTKA. Allograft failure was defined by an active extension deficit (AED) superior to 30° or a revision of the allograft because of its rupture. The analysis focused on the rate of mechanical and septic complications, survival without allograft revision, and functional outcomes.
RESULTS
The mean follow-up was 39.8 months ±15.6. The mean deficit of AED was 22.0° ± 24.4. At the last follow-up, 37.3% of the patients had an AED superior to 30° or an EMA rupture. The Kaplan-Meier survival without aseptic EMA failure (EMA revision and AED > 30°) at 24 and 48 months was 79.5 and 59.1%, respectively. At the last follow-up, 52.9% of the patients were satisfied. There were 15 complications (29.4%) on the EMA, with nine surgical reoperations for EMA failure (17.6%).
CONCOMITANT
TKA revision did not affect functional outcomes, mechanical complication rates, or allograft survival. The QT rupture subgroup had a significantly hixgher risk of EMA failure, particularly on the quadriceps tendon (P = 0.045).
CONCLUSION
Extensor mechanism allograft on TKA was a salvage procedure, with a satisfactory mid-term allograft survival rate. However, this procedure was associated with major morbidity and modest functional outcomes.